| pubmed-article:1680074 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1680074 | lifeskim:mentions | umls-concept:C0178795 | lld:lifeskim |
| pubmed-article:1680074 | lifeskim:mentions | umls-concept:C0015965 | lld:lifeskim |
| pubmed-article:1680074 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:1680074 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:1680074 | lifeskim:mentions | umls-concept:C0442123 | lld:lifeskim |
| pubmed-article:1680074 | lifeskim:mentions | umls-concept:C1879316 | lld:lifeskim |
| pubmed-article:1680074 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:1680074 | pubmed:dateCreated | 1991-10-24 | lld:pubmed |
| pubmed-article:1680074 | pubmed:abstractText | Twenty-six severely isoimmunized pregnancies managed exclusively with ultrasonographically guided intravascular fetal transfusions are reported. The mean gestational age plus and minus one standard deviation (+/- SD) was 26.3 +/- 3.6 weeks and the mean hematocrit (+/- SD) prior to initial transfusion was 20.6 +/- 6.7%. Four of seven hydropic fetuses and 9 of 19 without hydrops were less than or equal to 26 weeks gestation at the first transfusion. Overall survival was 85% (22/26). Survival was similar whether or not fetal hydrops was present (6/7 vs. 16/19) and whether or not the first transfusion was administered at less than or equal to 26 weeks gestation (10/13 vs. 12/13). | lld:pubmed |
| pubmed-article:1680074 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1680074 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1680074 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1680074 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1680074 | pubmed:month | May | lld:pubmed |
| pubmed-article:1680074 | pubmed:issn | 0020-7292 | lld:pubmed |
| pubmed-article:1680074 | pubmed:author | pubmed-author:SocolM LML | lld:pubmed |
| pubmed-article:1680074 | pubmed:author | pubmed-author:DooleyS LSL | lld:pubmed |
| pubmed-article:1680074 | pubmed:author | pubmed-author:NeyJ AJA | lld:pubmed |
| pubmed-article:1680074 | pubmed:author | pubmed-author:SilverR KRK | lld:pubmed |
| pubmed-article:1680074 | pubmed:author | pubmed-author:MacGregorS... | lld:pubmed |
| pubmed-article:1680074 | pubmed:author | pubmed-author:MillardD DDD | lld:pubmed |
| pubmed-article:1680074 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1680074 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:1680074 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1680074 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1680074 | pubmed:pagination | 41-6 | lld:pubmed |
| pubmed-article:1680074 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1680074 | pubmed:meshHeading | pubmed-meshheading:1680074-... | lld:pubmed |
| pubmed-article:1680074 | pubmed:meshHeading | pubmed-meshheading:1680074-... | lld:pubmed |
| pubmed-article:1680074 | pubmed:meshHeading | pubmed-meshheading:1680074-... | lld:pubmed |
| pubmed-article:1680074 | pubmed:meshHeading | pubmed-meshheading:1680074-... | lld:pubmed |
| pubmed-article:1680074 | pubmed:meshHeading | pubmed-meshheading:1680074-... | lld:pubmed |
| pubmed-article:1680074 | pubmed:meshHeading | pubmed-meshheading:1680074-... | lld:pubmed |
| pubmed-article:1680074 | pubmed:meshHeading | pubmed-meshheading:1680074-... | lld:pubmed |
| pubmed-article:1680074 | pubmed:meshHeading | pubmed-meshheading:1680074-... | lld:pubmed |
| pubmed-article:1680074 | pubmed:meshHeading | pubmed-meshheading:1680074-... | lld:pubmed |
| pubmed-article:1680074 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1680074 | pubmed:articleTitle | Perinatal outcome following intravascular transfusion in severely isoimmunized fetuses. | lld:pubmed |
| pubmed-article:1680074 | pubmed:affiliation | Department of Obstetrics and Gynecology, Northwestern University Medical School, Chicago, Illinois. | lld:pubmed |
| pubmed-article:1680074 | pubmed:publicationType | Journal Article | lld:pubmed |
